Randomised comparison of ceftriaxone and cefamandole therapy in lower respiratory tract infections in an elderly population

Patients with pneumonia or bronchitis were randomized to receive ceftriaxone or cefamandole. A total of 30 of 38 patients were evaluable, 16 in the ceftriaxone group (average age 66.3 years) and 14 in the cefamandole group (average age 69.4 years). All but one had underlying diseases. Patients usual...

Ausführliche Beschreibung